Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Experimental & Molecular Medicine ; : 145-149, 1998.
Artigo em Inglês | WPRIM | ID: wpr-35391

RESUMO

A partial fragment of novel sequence (arr, adriamycin-resistant related) was previously identified using the differential display (DD)-PCR technique with adriamycin-resistant L1210 variant (L1210AdR), which shows a typical multidrug resistant (MDR) phenotypes. The present research shows the isolation of full length arr cDNA sequence. To clone the full length cDNA of arr gene, DD-PCR fragments were subjected to 5'- and 3'-Rapid Amplification of cDNA End (RACE) method. The cloned arr cDNA consisted of 770 bases and contained an open reading frame of 153 bases, encoding a protein of 51 amino acid with the molecular mass of 4 kDa by in vitro translation reactions. Northern blot analysis showed that a 770 bases transcript arr gene was overexpressed in adriamycin-resistant L1210 variant, but not in the parent suggesting that the arr gene may be involved in the adriamycin-resistant phenotypes.


Assuntos
Camundongos , Sequência de Aminoácidos , Animais , Sequência de Bases , Northern Blotting , Clonagem Molecular , Primers do DNA , Doxorrubicina/farmacologia , Resistencia a Medicamentos Antineoplásicos/genética , Regulação Neoplásica da Expressão Gênica , Glicoproteínas/genética , Leucemia L1210/genética , Leucemia L1210/tratamento farmacológico , Dados de Sequência Molecular , Biossíntese de Proteínas
2.
Ciênc. cult. (Säo Paulo) ; 49(5/6): 370-7, Sept.-Dec. 1997. tab, graf
Artigo em Inglês | LILACS | ID: lil-214099

RESUMO

Several derivatives of well-known natural anticancer drugs have been synthesized and will continue to be, to overcome their delivering problems, or effectiveness. Characteristics such as poor solubility, metabolic inactivation, resistance development, rapid clearance or short half-life, adverse side effects like nausea, alopecia, anorexia are common undesirable limitations to their clinical use. Drug toxicity to less sensitive tumors as those in liver or brain is another aimed goal. Recent efforts to reverse undesirable physicochemical properties of well-established natural anticancer compounds are focused. Improved antitumor action of olivacine in L(1210) leukemia with slightly soluble halides with increased life span as well as "cured" animals was observed.


Assuntos
Humanos , Antineoplásicos Fitogênicos/farmacologia , Elipticinas/farmacologia , Leucemia L1210/tratamento farmacológico , Antineoplásicos Fitogênicos/uso terapêutico , Elipticinas/uso terapêutico , Sobrevivência Celular
3.
Rev. cuba. oncol ; 6(2): 245-8, mayo-ago. 1990. tab
Artigo em Espanhol | LILACS | ID: lil-92540

RESUMO

El (1-[2-cloroetil] 1-nitroso, 3 ciclohexil urea) (CCNU) es una droga antitumoral que forma parte actualmente de múltiples esquemas de poliquimioterapia en el tratamienmto de diferentes localizaciones y su obtención en el país aumentará la disponibilidad de este producto. El presente trabajo evalúa la actividad, en comparación con el producto comercial usado actualmente en la clínica oncológica y por los resultados obtenidos en los tumores experimentales utilizados, ambos productos manifiestan semejante actividad antitumoral


Assuntos
Camundongos , Animais , Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Leucemia L1210/tratamento farmacológico , Leucemia P388/tratamento farmacológico
4.
Rev. cuba. oncol ; 6(1): 107-11, ene.-abr. 1990. ilus
Artigo em Espanhol | LILACS | ID: lil-91566

RESUMO

El M-tiocarbamal (morfolinditiocarbamato de sodio) es un producto sintético con el cual en estos momentos se lleva a cabo el ensayo clínico fase I. Experimentalmente se combinó con el Cis-DDP en el tratamiento de la leucemia L-1210. Los resultados obtenidos evidencian la potenciación de la acción antitumoral del Cis-DDP cuando el M-tiocarbamal se administra simultáneo o después de la administración del citostático


Assuntos
Camundongos , Animais , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Cisplatino/uso terapêutico , Leucemia L1210/tratamento farmacológico , Tiocarbamatos/uso terapêutico
5.
Indian J Physiol Pharmacol ; 1989 Jul-Sep; 33(3): 171-4
Artigo em Inglês | IMSEAR | ID: sea-108415

RESUMO

Studies were carried out on the combination of Cimetidine (CMTD) with Cytoxan (CTX) in three murine tumors. While the combination significantly potentiated the anticancer effect of CTX in L1210 leukemia, the results with P388 leukemia were not significantly different. The results with Lewis Lung Carcinoma showed a consistent reduction in the number of metastases. However, there was no consistent concomitant prolongation in survival. The host strain, biology of the tumour and the drug used in combination with CMTD might be some of the factors responsible for the varied response.


Assuntos
Animais , Cimetidina/administração & dosagem , Ciclofosfamida/administração & dosagem , Quimioterapia Combinada , Feminino , Leucemia L1210/tratamento farmacológico , Leucemia P388/tratamento farmacológico , Leucemia Experimental/tratamento farmacológico , Neoplasias Pulmonares/tratamento farmacológico , Masculino , Camundongos , Camundongos Endogâmicos DBA , Transplante de Neoplasias
6.
Rev. cuba. farm ; 22(2): 33-41, mayo-ago. 1988. tab
Artigo em Espanhol | LILACS | ID: lil-74706

RESUMO

Se estudió la actividad antitumoral del 1,3 biscloroetil nitrosourea (BCNU) sintetizado en Cuba en dos tumores transplantables de ratón, las leucemias L-1210 y P-388, así como la toxicidad de diferentes esquemas de administración del producto en ratas albinas. El producto aumentó notablemente la supervivencia de los animales tratados con respecto al control en los tumores experimentales usados y manifestó efectos tóxicos notables en el sistema hematopoyético y el hígado


Assuntos
Ratos , Animais , Feminino , Leucemia L1210/tratamento farmacológico , Leucemia P388/tratamento farmacológico , Compostos de Nitrosoureia/uso terapêutico , Compostos de Nitrosoureia/toxicidade , Transplante de Neoplasias
7.
Rev. cuba. oncol ; 1(3): 351-5, sept.-dic. 1985. tab
Artigo em Espanhol | LILACS | ID: lil-41181

RESUMO

Se estudia la actividad antitumoral de extractos etanólicos de plantas que crecen en Cuba en ratones con leucemia P-388 y leucemia 1210, se realiza un tamizaje alcaloidal para las mismas especies con el empleo de reactivos precipitantes y la cromatografía en placa delgada. Las plantas pertenecen a las familias Euphorbiaceae, Rubiaceae, Leguminoseae, Clusiaceae, Moraceae, Sapotaceae, Menispermeaceae y Sterculiaceae. Contienen alcaloides las especies Aleurites trisperma Blanco, Aleurites moluccana (L) Wiel, Pithecellobium dulce (Roxb) Benth, Tamarindus indica L., Chlorophora trinctoria L. Gaud e Hyperbaena racemosa Ukb. Tienen actividad antitumoral Chamaesyce buxifolia (Lam) Small, Andira inermis (Sw) H B K y Clusia rosea Jacq


Assuntos
Ratos , Animais , Antineoplásicos Fitogênicos/uso terapêutico , Leucemia L1210/tratamento farmacológico , Leucemia P388/tratamento farmacológico , Cuba
8.
Indian J Physiol Pharmacol ; 1984 Jan-Mar; 28(1): 21-6
Artigo em Inglês | IMSEAR | ID: sea-108730

RESUMO

The ability of Amphotericin B ('Fungizone') to alter the natural resistance of leukemia L1210 to vincristine was studied in BDF1 mice Neither Fungizone nor the "solubilizing agent" sodium deoxycholate, when used in combination with vincristine potentiated the activity of the drug against L1210. There was no change in the activity pattern of 5-fluorouracil against L1210 or vincristine against P388 lymphocytic leukemia respectively, which are sensitive to these drugs. Thus, both Fungizone and sodium deoxycholate failed to improve the activity of the drugs in either a naturally resistant or sensitive murine leukemia in vivo.


Assuntos
Anfotericina B/administração & dosagem , Animais , Protocolos de Quimioterapia Combinada Antineoplásica , Ácido Desoxicólico/administração & dosagem , Esquema de Medicação , Resistência a Medicamentos , Sinergismo Farmacológico , Fluoruracila/administração & dosagem , Leucemia L1210/tratamento farmacológico , Leucemia P388/tratamento farmacológico , Leucemia Experimental/tratamento farmacológico , Camundongos , Camundongos Endogâmicos DBA , Transplante de Neoplasias , Vincristina/administração & dosagem
9.
Indian J Physiol Pharmacol ; 1983 Apr-Jun; 27(2): 83-91
Artigo em Inglês | IMSEAR | ID: sea-108025

RESUMO

Semecarpus anacardium Linn.f. nuts were extracted by using non-polar and polar organic solvents. Hot methanol extract and a resinous fraction, isolated from it, showed antitumour activity against P388 lymphocytic leukaemia in BDF1 mice as judged by their median survival time. Petroleum ether extract and its chromatographically isolated fraction were obtained. The latter fraction was distilled under reduced pressure to get an orange-coloured oil, (b.p. 200-20 degrees/2-3 mm). Both had antitumour activity. The orange-coloured oil, on further distillation under reduced pressure, yielded Bhilawanol. An acetyl derivative of the oil was also obtained. The latter two also had antitumour activity.


Assuntos
Animais , Antineoplásicos Fitogênicos , Leucemia L1210/tratamento farmacológico , Leucemia P388/tratamento farmacológico , Camundongos , Óleos/farmacologia , Extratos Vegetais/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA